Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0000929638-25-004297·Lind Global Fund III LP
Schedule 13G ownership disclosure
SILEXION THERAPEUTICS CORP
Ordinary shares, par value $0.0135 per share · CUSIP: G1281K122
Event date: 2025-09-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Lind Global Fund III LP
Shares: 212,500 · Class: 6.4%
- Lind Global Partners III LLC
Shares: 212,500 · Class: 6.4%
- EASTON JEFF
Shares: 212,500 · Class: 6.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000929638-25-004297
- Form type
- SCHEDULE 13G/A
- Filer
- Lind Global Fund III LP
- CIK
- CIK 2071860
- Filed
- Nov 14, 2025
- Reporting period
- Sep 30, 2025
- Description
- Schedule 13G beneficial ownership